Prevalence and severity of lower urinary tract symptoms in the third trimester of pregnancy.
Lower urinary tract symptoms
Pelvic floor disorders
Pregnancy
Quality of life
Urinary incontinence
Women’s health
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
03
01
2023
accepted:
19
02
2023
medline:
19
9
2023
pubmed:
5
4
2023
entrez:
4
4
2023
Statut:
ppublish
Résumé
Pregnancy is a risk factor for urinary disorders, mainly in the third trimester. Lower urinary tract symptoms (LUTS) are often underreported by health care professionals and significantly impact the quality of life of pregnant women. Our objective is to analyse lower urinary tract function during the third trimester of pregnancy and assess the impact of traditional risk factors for pelvic floor dysfunctions on bladder health in pregnant women. This is a secondary analysis of a multicentre cross-sectional study. Third-trimester pregnant women aged 18 years or older anonymously filled in the "Italian Pelvic Floor Questionnaire for pregnant and postpartum women" questionnaire, validated for pelvic floor disorders in pregnancy and postpartum. A total of 927 pregnant patients completed the questionnaire. Among them, 97.3% complained of at least one urinary disorder. Frequency was the symptom reported most often (77.3%), whereas nocturnal enuresis was the least reported (17%). Despite the high prevalence of LUTS in our sample, only 13.4% reported that they negatively impact their quality of life. Overweight and obesity, advanced maternal age, smoking, family history of pelvic floor disorders and poor pelvic floor contraction capacity were confirmed to be risk factors for the onset of LUTS, even in our population. Urinary symptoms are extremely common in the third trimester and significantly affect the quality of life of pregnant women. Since overweight, obesity, smoking and reduced pelvic floor contractility emerged as modifiable risk factors for the development of these symptoms, prevention and adequate counselling are cornerstones of pregnancy care.
Identifiants
pubmed: 37014397
doi: 10.1007/s00192-023-05515-3
pii: 10.1007/s00192-023-05515-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2155-2161Informations de copyright
© 2023. The International Urogynecological Association.
Références
Palmieri S, De Bastiani SS, Degliuomini R, et al. Prevalence and severity of pelvic floor disorders in pregnant and postpartum women. Int J Gynecol Obstet. 2022;158(2):346–51. https://doi.org/10.1002/ijgo.14019 .
doi: 10.1002/ijgo.14019
Balik G, Güven SGG, Tekin YB, et al. Lower urinary tract symptoms and urinary incontinence during pregnancy. Low Urin Tract Symptoms. 2016;8(2):120–4. https://doi.org/10.1111/luts.12082 .
Dinç A. Prevalence of urinary incontinence during pregnancy and associated risk factors. Low Urin Tract Symptoms. 2018;10(3):303–7. https://doi.org/10.1111/luts.12182 .
doi: 10.1111/luts.12182
pubmed: 28675636
Metz M, Junginger B, Henrich W, Baeßler K. Development and validation of a questionnaire for the assessment of pelvic floor disorders and their risk factors during pregnancy and post partum. Geburtshilfe Frauenheilkd. 2017;77(04):358–65. https://doi.org/10.1055/s-0043-102693 .
doi: 10.1055/s-0043-102693
pubmed: 28552999
pmcid: 5406235
Palmieri S, Cola A, Ceccherelli A, Manodoro S, Frigerio M, Vergani P. Italian validation of the German pelvic floor questionnaire for pregnant and postpartum women. Eur J Obstet Gynecol Reprod Biol. 2020;248:133–6. https://doi.org/10.1016/j.ejogrb.2020.03.032 .
doi: 10.1016/j.ejogrb.2020.03.032
pubmed: 32203824
Yohay D, Weintraub AY, Mauer-Perry N, et al. Prevalence and trends of pelvic floor disorders in late pregnancy and after delivery in a cohort of Israeli women using the PFDI-20. Eur J Obstet Gynecol Reprod Biol. 2016;200:35–9. https://doi.org/10.1016/j.ejogrb.2016.02.037 .
Avery KNL, Bosch JL, Gotoh M, et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol. 2007;177(1):39–49. https://doi.org/10.1016/j.juro.2006.08.075 .
doi: 10.1016/j.juro.2006.08.075
pubmed: 17161997
Maguire T, Abdelrahman A, Maguire A. Pilot study exploring the incidence of lower urinary tract symptoms during pregnancy in a district general hospital in Northern Ireland: a prospective survey. Int Urogynecol J. 2021;32(10):2807–17. https://doi.org/10.1007/s00192-021-04718-w/Published .
doi: 10.1007/s00192-021-04718-w/Published
pubmed: 33666695
Martins G, Soler ZASG, Cordeiro JA, Amaro JL, Moore KN. Prevalence and risk factors for urinary incontinence in healthy pregnant Brazilian women. Int Urogynecol J. 2010;21(10):1271–7. https://doi.org/10.1007/s00192-010-1185-2 .
doi: 10.1007/s00192-010-1185-2
pubmed: 20502875
Liang CC, Chang SD, Lin SJ, Lin YJ. Lower urinary tract symptoms in primiparous women before and during pregnancy. Arch Gynecol Obstet. 2012;285(5):1205–10. https://doi.org/10.1007/s00404-011-2124-2 .
doi: 10.1007/s00404-011-2124-2
pubmed: 22042166
Thomason AD, Miller JM, DeLancey JO. Urinary incontinence symptoms during and after pregnancy in continent and incontinent primiparas. Int Urogynecol J. 2007;18(2):147–51. https://doi.org/10.1007/s00192-006-0124-8 .
doi: 10.1007/s00192-006-0124-8
Saffarini JH, Ahmad QT, Samara AM, et al. Assessment of lower urinary tract symptoms during pregnancy: an observational cross-sectional study from Palestine. BMC Pregnancy Childbirth 2021;21(1):21(1):84, https://doi.org/10.1186/s12884-021-03567-1 .
Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT Study. Epidemiology of incontinence in the county of Nord-Trøndelag. BMC Pregnancy Childbirth. 2000;53(11):1150–7
Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretics. Arch Dis Child. 1974;49(4):259–63.
doi: 10.1136/adc.49.4.259
pubmed: 4830115
pmcid: 1648743
Buckley BS, Lapitan MC. Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom. Int J Clin Pract. 2009;63(4):568–73. https://doi.org/10.1111/j.1742-1241.2008.01974.x .
doi: 10.1111/j.1742-1241.2008.01974.x
pubmed: 19175680
Li Z, Xu T, Zhang L, Zhu L. Prevalence, potential risk factors, and symptomatic bother of lower urinary tract symptoms during and after pregnancy. Low Urin Tract Symptoms. 2009;11(4):217–23. https://doi.org/10.1111/luts.12274 .
doi: 10.1111/luts.12274
Dagher RK, Bruckheim HE, Colpe LJ, Edwards E, White DB. Perinatal depression: challenges and opportunities. J Womens Health. 2021;30(2):154–9. https://doi.org/10.1089/jwh.2020.8862 .
doi: 10.1089/jwh.2020.8862
Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008;27(8):749–57. https://doi.org/10.1002/nau.20635 .
doi: 10.1002/nau.20635
pubmed: 18951445
Kocaöz S, Talas MS, Atabekoǧlu CS. Urinary incontinence in pregnant women and their quality of life. J Clin Nurs. 2010;19(23–24):3314–3323. https://doi.org/10.1111/j.1365-2702.2010.03421.x .
doi: 10.1111/j.1365-2702.2010.03421.x
pubmed: 20955482
Hansen BB, Svare J, Viktrup L, Jørgensen T, Lose G. Urinary incontinence during pregnancy and 1 year after delivery in primiparous women compared with a control group of nulliparous women. Neurourol Urodyn. 2012;31(4):475–80. https://doi.org/10.1002/nau.21221 .
doi: 10.1002/nau.21221
pubmed: 22267117
Lin KL, Shen CJ, Wu MP, Long CY, Wu CH, Wang CL. Comparison of low urinary tract symptoms during pregnancy between primiparous and multiparous women. Biomed Res Int. 2014;2014:303697. https://doi.org/10.1155/2014/303697 .
doi: 10.1155/2014/303697
pubmed: 25431763
pmcid: 4241740
Bodner-Adler B, Kimberger O, Laml T, et al. Prevalence and risk factors for pelvic floor disorders during early and late pregnancy in a cohort of Austrian women. Arch Gynecol Obstet. 2019;300(5):1325–30. https://doi.org/10.1007/s00404-019-05311-9 .
doi: 10.1007/s00404-019-05311-9
pubmed: 31599348
pmcid: 6814848